Cnubben N H, Vervoort J, Boersma M G, Rietjens I M
Department of Biochemistry, Agricultural University, Wageningen, The Netherlands.
Biochem Pharmacol. 1995 May 11;49(9):1235-48. doi: 10.1016/0006-2952(95)00043-y.
The cytochrome P450 catalysed biotransformation of 4-halogenated anilines was studied in vitro with special emphasis on the dehalogenation to 4-aminophenol metabolites. The results demonstrated that a fluorine substituent at the C4 position was more easily eliminated from the aromatic ring than a chloro-, bromo- or iodo-substituent. HPLC analysis of in vitro biotransformation patterns revealed that the dehalogenation of the C4-position was accompanied by formation of non-halogenated 4-aminophenol, without formation of NIH-shifted metabolites. Changes in the apparent Vmax for the microsomal oxidative dehalogenation appeared to correlate with the electronegativity of the halogen substituent at C4, the fluorine substituent being the one most easily eliminated. A similar decrease in the rate of dehalogenation from a fluoro- to a chloro- to a bromo- to an iodo-substituent was observed in a system with purified reconstituted cytochrome P450 IIB1, in a tertiair butyl hydroperoxide supported microsomal cytochrome P450 system as well as in a system with microperoxidase 8. This microperoxidase 8 is a haem-based mini-enzyme without a substrate binding site, capable of catalysing cytochrome P450-like reaction chemistry. Together, these results excluded the possibility that the difference in the rate of dehalogenation with a varying C4-halogen substituent arose from a change in the contribution of cytochrome P450 enzymes involved in oxidative dehalogenation with a change in the halogen substituent. Rather, they strongly suggested that the difference was indeed due to an intrinsic electronic parameter of the various C4 halogenated anilines dependent on the type of halogen substituent. Additional in vitro experiments with polyfluorinated anilines demonstrated that elimination of the C4-fluorine substituent became more difficult upon the introduction of additional electron withdrawing fluorine substituents in the aniline-ring. 19F-NMR analysis of the metabolite patterns showed that the observed decrease in 4-aminophenol formation was accompanied by a metabolic switch to 2-aminophenols and N-hydroxyanilines, while products resulting from NIH-type mechanisms were not observed. For a C4-chloro-, bromo-, or iodo-substituted 2-fluoroaniline the Vmax for the oxidative dehalogenation was reduced by the additional electron withdrawing fluorine substituent at the C2 position in a similar way.(ABSTRACT TRUNCATED AT 400 WORDS)
我们在体外研究了细胞色素P450催化的4-卤代苯胺的生物转化,特别关注其脱卤生成4-氨基酚代谢物的过程。结果表明,与氯、溴或碘取代基相比,4位的氟取代基更容易从芳环上消除。体外生物转化模式的HPLC分析显示,4位的脱卤伴随着非卤代4-氨基酚的形成,而未形成NIH迁移代谢物。微粒体氧化脱卤的表观Vmax变化似乎与4位卤素取代基的电负性相关,氟取代基是最容易被消除的。在含有纯化重组细胞色素P450 IIB1的系统、叔丁基过氧化氢支持的微粒体细胞色素P450系统以及含有微过氧化物酶8的系统中,观察到从氟取代基到氯取代基、再到溴取代基、最后到碘取代基的脱卤速率有类似的下降。这种微过氧化物酶8是一种基于血红素的微型酶,没有底物结合位点,能够催化类似细胞色素P450的反应化学。总之,这些结果排除了随着4位卤素取代基变化脱卤速率差异源于参与氧化脱卤的细胞色素P450酶的贡献随卤素取代基变化而改变的可能性。相反,它们强烈表明这种差异确实是由于各种4-卤代苯胺依赖于卤素取代基类型的内在电子参数。用多氟代苯胺进行的额外体外实验表明,在苯胺环中引入额外的吸电子氟取代基后,4位氟取代基的消除变得更加困难。代谢物模式的19F-NMR分析表明,观察到的4-氨基酚形成减少伴随着代谢转向2-氨基酚和N-羟基苯胺,而未观察到NIH型机制产生的产物。对于4-氯、溴或碘取代的2-氟苯胺,2位额外的吸电子氟取代基以类似方式降低了氧化脱卤的Vmax。(摘要截断于400字)